Gastrointestinal perforation during treatment with erlotinib plus bevacizumab in two patients with non-small cell lung cancer exhibiting epidermal growth factor receptor mutations: A case report

Teppei Yamaguchi, Yusuke Gotoh, Hidekazu Hattori, Hidetoshi Katsuno, Kazuyoshi Imaizumi

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Gastrointestinal perforation during treatment with erlotinib plus bevacizumab in two patients with non-small cell lung cancer exhibiting epidermal growth factor receptor mutations: A case report'. Together they form a unique fingerprint.

Medicine & Life Sciences